Publicacións nas que colabora con Eduardo Fernandez Megia (22)

2021

  1. Unveiling an NMR-Invisible Fraction of Polymers in Solution by Saturation Transfer Difference

    ACS Macro Letters, Vol. 10, Núm. 12, pp. 1474-1479

2019

  1. Polysaccharides meet dendrimers to fine-tune the stability and release properties of polyion complex micelles

    Polymer Chemistry, Vol. 10, Núm. 34, pp. 4709-4717

2015

  1. Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection

    Journal of Cerebral Blood Flow and Metabolism, Vol. 35, Núm. 3, pp. 469-475

2014

  1. An aquaporin 4 antisense oligonucleotide loaded, brain targeted nanoparticulate system design

    Pharmazie, Vol. 69, Núm. 5, pp. 340-345

  2. Comparative in vitro studies on PBN loaded nanoparticles prepared by biodegradable chitosan, PLGA polymersand their PEGylated block copolymers

    Journal of Drug Delivery Science and Technology, Vol. 24, Núm. 2, pp. 148-152

  3. GATG dendrimers and PEGylated block copolymers: From synthesis to bioapplications

    AAPS Journal, Vol. 16, Núm. 5, pp. 948-961

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

  2. Chitosan hydrophobic domains are favoured at low degree of acetylation and molecular weight

    Polymer, Vol. 54, Núm. 8, pp. 2081-2087

  3. Disclosing an NMR-invisible fraction in chitosan and PEGylated copolymers and its role on the determination of degrees of substitution

    Molecular Pharmaceutics, Vol. 10, Núm. 8, pp. 3225-3231

2012

  1. Chitosan Copolymers for Biopharmaceuticals

    Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics (John Wiley and Sons), pp. 333-380

2011

  1. NMR methods for unravelling the spectra of complex mixtures

    Natural Product Reports, Vol. 28, Núm. 1, pp. 78-98

2010

  1. Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: An application for p DNA and siRNA delivery

    Pharmaceutical Research, Vol. 27, Núm. 12, pp. 2544-2555

  2. Dynamics of chitosan by 1H NMR relaxation

    Biomacromolecules, Vol. 11, Núm. 8, pp. 2079-2086

  3. The dynamics of GATG glycodendrimers by NMR diffusion and quantitative 13C relaxation

    Physical Chemistry Chemical Physics, Vol. 12, Núm. 25, pp. 6587-6589

2009

  1. A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection

    Journal of Neuroscience, Vol. 29, Núm. 44, pp. 13761-13769

  2. Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of PEGylation degree on in vitro and in vivo gene transfer

    Journal of Biomedical Nanotechnology, Vol. 5, Núm. 2, pp. 162-171

  3. Preparation and evaluation of alpha-phenyl-n-tert-butyl nitrone (PBN)-encapsulated chitosan and PEGylated chitosan nanoparticles

    Pharmazie, Vol. 64, Núm. 7, pp. 436-439

2007

  1. Conjugation of bioactive ligands to PEG-grafted chitosan at the distal end of PEG

    Biomacromolecules, Vol. 8, Núm. 3, pp. 833-842

  2. Paramagnetic NMR relaxation in polymeric matrixes: Sensitivity enhancement and selective suppression of embedded species (1H and 13C PSR filter)

    Journal of the American Chemical Society, Vol. 129, Núm. 49, pp. 15164-15173

2006

  1. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: Effect of chitosan pegylation degree

    Journal of Controlled Release, Vol. 111, Núm. 3, pp. 299-308